Key priority area

Improve access to neoadjuvant therapy, including through clinical trials, in pancreatic cancer

Strategies and activities

Each key priority area has supporting strategies and associated activities for implementation in the short, medium or long term that have been identified to achieve the priority. Click on the strategies below to explore these in more detail.


Establish routine access to neoadjuvant therapy


Short term

  • Promote awareness of the benefits of chemotherapy treatment options, including neoadjuvant therapy

Medium term

  • Design and implement standardised approaches for access to neoadjuvant therapy including through clinical trials, leveraging technology and innovation